Egea Biosciences Overview

  • Founded
  • 2000

  • Status
  • Acquired/​Merged

  • Employees
  • 40

  • Latest Deal Type
  • M&A

Egea Biosciences General Information


Developer of protein drugs. The company's technology platform creates large libraries of proteins with directed single amino acid changes based on any imagined structure as programmed in a computer in order to revolutionize protein drug development and optimization.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 6759 Mesa Ridge Road
  • Suite 100
  • San Diego, CA 92121
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Egea Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 18-May-2004 Completed Generating Revenue
5. Grant 16-Jan-2004 00000 Completed Generating Revenue
4. Grant 31-May-2003 00000 Completed Generating Revenue
3. Grant 31-Jan-2002 00000 Completed Generating Revenue
2. Grant 28-Dec-2000 $317K Completed Generating Revenue
1. Early Stage VC 01-Jan-2000 Completed Startup
To view Egea Biosciences’s complete valuation and funding history, request access »

Egea Biosciences Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Egea Biosciences Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hamilton BioVentures Venture Capital Minority 000 0000 000000 0
United States Army Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
To view Egea Biosciences’s complete investors history, request access »